BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1992915)

  • 1. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
    Futami K; Arima S; Yoshimura S; Okamoto T; Yamasaki K; Koto T; Yamasaki S; Kawahara K; Ikuno T
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):215-20. PubMed ID: 1992915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
    Kanimoto Y; Suzuki Y; Miwa Y; Akino H; Isomatu Y; Okada K
    Hinyokika Kiyo; 1991 Mar; 37(3):229-33. PubMed ID: 1648873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on tissue concentration of tegafur, 5-fluorouracil, uracil after UFT administration together with the study of microangiography of colorectal cancer].
    Shimoyama T; Shimizu T; Kusano H; Ishikawa H; Miyashita K; Nakazaki T; Yasutake T; Yoshida A; Yoshida K; Ogawa T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):125-30. PubMed ID: 8422176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the pharmacokinetics of UFT in patients with hepatocellular carcinoma associated with cirrhosis].
    Une Y; Ito Y; Ogasawara K; Nagafuchi E; Matsuoka S; Misawa K; Sato N; Nakajima Y; Uchino J
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3153-9. PubMed ID: 2551251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pre- and post-operative adjuvant chemotherapy of colorectal cancer. Part 1. Drug concentration in tissues following UFT administration].
    Tomita M; Shimoyama T; Hirano T; Nakagoe T; Shimizu T; Kusano H; Fukuda Y; Eida K; Ishii T; Kotake Y
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3239-43. PubMed ID: 3143310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between antitumor activity and the inhibition of thymidylate synthase after oral administration of UFT in nude mice bearing human tumor].
    Fujita M; Fujita F; Uchida J; Takeda S; Yamada Y; Taguchi T
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):627-32. PubMed ID: 2108611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur].
    Suzuki M; Sekiguchi I; Tamada T; Nishida M
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1399-404. PubMed ID: 2530293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacodynamic study on the effectiveness of UFT against cancer of gastro-intestinal (GI) tract].
    Seo Y; Matsuoka H; Kakeji Y; Morita M; Ohno S; Matsukuma A; Tomoda H; Furusawa M
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1775-80. PubMed ID: 8379669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of preoperative combination therapy with UFT + CDDP in patients with gastric and colorectal cancer--concomitant effects based on the thymidylate synthase inhibitory rat].
    Mitsuishi K; Umeno T; Tanaka S; Kimura H; Fuchino Y; Tomita A; Ikeda S
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1119-24. PubMed ID: 9239165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [5-FU concentration in the blood and tissue of patients with gastric and colorectal cancer after administration of UFT or tegafur].
    Arima S; Futami K; Shigeta M; Kinashi M; Shimura H
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2618-24. PubMed ID: 3090940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
    Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
    Inaba S; Kondo Y; Tsuchiya K; Kawai K; Ogino A; Umeda T; Ueda Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2175-80. PubMed ID: 1444483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do the expression of CD44, apoptosis and thymidylate synthase inhibition rate correlate with the efficacy of chemotherapy in colorectal cancer?
    Tachikawa D; Arima S; Futami K; Iwashita A
    Anticancer Res; 2000; 20(1C):595-600. PubMed ID: 10769701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic study in biochemical modulation therapy of UFT with leucovorin tablet].
    Yamamura T; Oikawa H; Hanai A; Matsuzaki H; Akaishi O; Seo K; Kikuchi K; Ozasa T; Tsukikawa S; Yamaguchi S
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):245-51. PubMed ID: 7857100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Innate resistance to thymidylate synthase inhibition after 5-fluorouracil treatment--a rationale of combined use of cisplatin and its optimal administration dose].
    Omura K; Hashimoto T; Kawakami K; Kanehira E; Watanabe T; Hirano K; Watanabe S; Watanabe Y; Shirasaka T
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2007-11. PubMed ID: 8085851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
    Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
    Sekiguchi I; Suzuki M; Tamada T; Nishida M
    Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
    Shirasaka T; Nakano K; Takechi T; Satake H; Uchida J; Fujioka A; Saito H; Okabe H; Oyama K; Takeda S; Unemi N; Fukushima M
    Cancer Res; 1996 Jun; 56(11):2602-6. PubMed ID: 8653704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.